Articles with public access mandates - Renaud SeigneuricLearn more
Not available anywhere: 2
Development of a new methodology to determine size differences of nanoparticles with nanoparticle tracking analysis
Y Pellequer, G Zanetta, JM Rebibou, I Severin, MC Chagnon, G Zissel, ...
Applied Nanoscience 11 (7), 2129-2141, 2021
Mandates: Swiss Cancer League
Quantifying Gp96/Grp94 Complexes Preparations for Vaccines: A Key Step Often Inaccurate
A Seignez, É Kohli, C Garrido, R Seigneuric
Current Medicinal Chemistry 21 (2), 153-163, 2014
Mandates: National Institute of Health and Medical Research, France
Available somewhere: 10
From nanotechnology to nanomedicine: applications to cancer research
R Seigneuric, L Markey, D SA Nuyten, C Dubernet, C TA Evelo, E Finot, ...
Current Molecular Medicine 10 (7), 640-652, 2010
Mandates: National Institute of Health and Medical Research, France
Restoring anticancer immune response by targeting tumor-derived exosomes with a HSP70 peptide aptamer
J Gobbo, G Marcion, M Cordonnier, AMM Dias, N Pernet, A Hammann, ...
Journal of the National Cancer Institute 108 (3), djv330, 2016
Mandates: Swiss Cancer League
HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia
JB Arlet, JA Ribeil, F Guillem, O Negre, A Hazoume, G Marcion, ...
Nature 514 (7521), 242-246, 2014
Mandates: National Institute of Health and Medical Research, France
N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death
F Dufour, T Rattier, S Shirley, G Picarda, AA Constantinescu, A Morlé, ...
Cell Death & Differentiation 24 (3), 500-510, 2017
Mandates: Swiss National Science Foundation, US National Institutes of Health, Swiss …
Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracil–based chemotherapy
A Collura, A Lagrange, M Svrcek, L Marisa, O Buhard, A Guilloux, ...
Gastroenterology 146 (2), 401-411. e1, 2014
Mandates: Swiss Cancer League
The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer
MHW Starmans, KC Chu, S Haider, F Nguyen, R Seigneuric, ...
Radiotherapy and Oncology 102 (3), 436-443, 2012
Mandates: Canadian Institutes of Health Research, Ontario Institute for Cancer Research
Translational control is a major contributor to hypoxia induced gene expression
T van den Beucken, MG Magagnin, B Jutten, R Seigneuric, P Lambin, ...
Radiotherapy and Oncology 99 (3), 379-384, 2011
Mandates: Canadian Institutes of Health Research, Ontario Institute for Cancer Research
XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia
F Guillem, M Dussiot, E Colin, T Suriyun, JB Arlet, N Goudin, G Marcion, ...
Haematologica 105 (9), 2240, 2020
Mandates: Agence Nationale de la Recherche
Nanofitins targeting heat shock protein 110: An innovative immunotherapeutic modality in cancer
G Marcion, F Hermetet, F Neiers, B Uyanik, L Dondaine, AMM Dias, ...
International Journal of Cancer 148 (12), 3019-3031, 2021
Mandates: Agence Nationale de la Recherche
Decoding artificial intelligence and machine learning concepts for cancer research applications
R Seigneuric, I Bichindaritz
OSF Preprints. September 7, 2020
Mandates: Swiss Cancer League
Publication and funding information is determined automatically by a computer program